ALLYRNA

Hong Kong, Hong Kong · Founded 2025 · Privately Held (backing)

Developer of RNA-based biopharmaceutical technologies intended to accelerate therapeutic innovation in precision medicine. ALLYRNA is based in Hong Kong, Hong Kong and was founded in 2025. It has raised $10 million.

Last price · $/share

—

Implied valuation

—

Total raised

$10.0M

Last round

—

How much has ALLYRNA raised?

$10.0Macross 0 recorded rounds

Free account

More of ALLYRNA with a free account

·Watch ALLYRNA: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

ALLYRNA investors

4 investors are on record for ALLYRNA, including Plaisance Capital, Gaorong Ventures, Jifeng Ventures and Qiji Investment.

For fundraisers

Raising for a company like ALLYRNA?

4 investors have backed ALLYRNA.

See all 4 investors →

Frequently asked about ALLYRNA

How much has ALLYRNA raised?: ALLYRNA has raised $10.0M in total across 0 recorded funding rounds.